Walgreens and Rite Aid are cutting their deal price - and Rite Aid's stock is dropping
Walgreens will now pay between $6.50 and $7 per share for Rite Aid.
The drugstore chain had originally agreed to pay Rite Aid at $9 per share, valuing the company around $9.4 billion, when it announced the deal back in October 2015.
They may also sell more drugstores than previously planned, according to the report.
The deadline for the deal has been pushed back from January 27 to July 31, according to the Bloomberg report. Bloomberg last week reported that the two companies would likely miss their January deadline due to regulatory concerns.
That follows an earlier missed deadline in October 2016. A report from the New York Post at that time said the supermarket chain Kroger may no longer be interested in acquiring 650 stores from the two companies as part of that deal.
Rite Aid's stock dropped about 17% in premarket trading.
- A centenarian who starts her day with gentle exercise and loves walks shares 5 longevity tips, including staying single
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Having an regional accent can be bad for your interviews, especially an Indian one: study
- Dirty laundry? Major clothing companies like Zara and H&M under scrutiny for allegedly fuelling deforestation in Brazil
- 5 Best places to visit near Darjeeling
- Climate change could become main driver of biodiversity decline by mid-century: Study
- RBI initiates transition plan: Small finance banks to ascend to universal banking status
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market